| Identification | More | [Name]
ETHYL 5-FLUOROINDOLE-2-CARBOXYLATE | [CAS]
348-36-7 | [Synonyms]
2-CARBETHOXY-5-FLUOROINDOLE
5-FLUORO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER
5-FLUOROINDOLE-2-CARBOXYLIC ACID ETHYL ESTER
ETHYL 5-FLUORO-1H-INDOLE-2-CARBOXYLATE
ETHYL 5-FLUOROINDOLE-2-CARBOXYLATE
Ethyl 5-fluoroindole
5-Fluoro-2-indolecarboxylic acid ethyl ester
2-ETHYLFORMATE-5-FLUOROINDOLE
5-F-ICA-OEt | [Molecular Formula]
C11H10FNO2 | [MDL Number]
MFCD00152076 | [Molecular Weight]
207.2 | [MOL File]
348-36-7.mol |
| Chemical Properties | Back Directory | [Melting point ]
146-150 °C | [Boiling point ]
345.9±22.0 °C(Predicted) | [density ]
1.291±0.06 g/cm3(Predicted) | [storage temp. ]
Inert atmosphere,Room Temperature | [pka]
14.17±0.30(Predicted) | [λmax]
281nm(EtOH)(lit.) | [BRN ]
170254 | [InChIKey]
VIKOQTQMWBKMNA-UHFFFAOYSA-N | [CAS DataBase Reference]
348-36-7(CAS DataBase Reference) |
| Safety Data | Back Directory | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S22:Do not breathe dust .
S24/25:Avoid contact with skin and eyes . | [WGK Germany ]
3
|
| Hazard Information | Back Directory | [Chemical Properties]
light yellow powder | [Uses]
- Reactant for preparation of antitumor agents
- Reactant for preparation of antihyperlipidemic agents
- Reactant for preparation of factor Xa inhibitors
- Reactant for preparation of potential antiarrhythmic agents
- Reactant for preparation of inhibitors of the cytosolic phospholipase A2
- Reactant for preparation of thromboxane receptor antagonist and thromboxane synthase inhibitor via Mitsunobu reaction
| [Uses]
Reactant for preparation of antitumor agents 1 Reactant for preparation of antihyperlipidemic agents 2 Reactant for preparation of factor Xa inhibitors 3 Reactant for preparation of potential antiarrhythmic agents 4 Reactant for preparation of inhibitors of the cytosolic phospholipase A2 5 Reactant for preparation of thromboxane receptor antagonist and thromboxane synthase inhibitor via Mitsunobu reaction 6 |
|
|